{"transactions":[{"id":1896487,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113616,"kind":"person","name":"Garfield Jon","position":1,"cik":"0001336751","reported_name":"Garfield Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-11T21:21:00.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock award was granted pursuant to the Blue Water Biotech, Inc. Amended and Restated 2022 Equity Incentive Plan. 50% of the stock award will vest on August 17, 2023; 25% of the award will vest on August 17, 2024; and the remaining 25% of the award will vest on August 18, 2025."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001213900-23-038668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1336751/000121390023038668/ownership.xml","form_type":"4"}},{"id":2252931,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113616,"kind":"person","name":"Garfield Jon","position":1,"cik":"0001336751","reported_name":"Garfield Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T10:46:25.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Garfield on May 4, 2022. The Options vest and become exercisable as follows: 25% of the Options will vest on September 15, 2022 and the remainder of the Options vest in equal monthly installments over the following 36 months."}],"balance_after":100000,"derivative":{"exercise_price":6.45,"expiration_date":"2032-05-04","underlying":"Common Stock, par value $0.00001 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-22-030003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1336751/000121390022030003/ownership.xml","form_type":"4"}}]}